New Search

If you are not happy with the results below please do another search

37 search results for: lgc capital

1

LGC Capital Increases Size of Oversubscribed Private Placement Financing and Provides Update on Quebec Cannabis Investment

MONTREAL, November 21, 2017 – LGC Capital Ltd. (TSXV: LG) (“LGC”) is pleased to provide an update on LGC’s previously-announced private placement financing and its proposed investment in new Quebec cannabis-focused AAA Trichomes. Private Placement Financing – Over Subscribed LGC is pleased to announce that in light of very heavy demand, it has decided to increase the maximum amount of its […]

2

LGC Capital Ltd. Announces Private Placement

MONTREAL, Nov. 16, 2017  – LGC Capital Ltd. (TSXV: LG) (“LGC”) is pleased to announce that it has received conditional approval from the TSX Venture Exchange for a private placement of units at a price of $0.15 per unit. The private placement will be in a minimum amount of $1 million (6,666,666 units) and a […]

3

LGC Capital’s Strategic Partner Creso Pharma achieves landmark milestone with the commercial launch of first animal health product in Switzerland

MONTREAL, Nov. 14, 2017 – LGC Capital Ltd.  (TSXV: LG) (“LGC”) is pleased to announce its strategic partner Creso Pharma (CPH-ASX) disseminated the following news release yesterday about the launch of its cannabis-based product anibidiol® in Switzerland and Lichtenstein. Of note, Creso Pharma and LGC have agreed that LGC will be spearheading the distribution of this product in Southern Africa and Canada through LGC’s […]

4

Creso Pharma and LGC Capital Announce Strategic Alliance

Montreal, Québec, Canada and Perth, Australia – November 9, 2017 – Creso Pharma (“Creso”), the Australian listed and Swiss based pharmaceutical company, and Canadian listed LGC Capital Ltd. (“LGC”), jointly announce the formation of a new and exciting strategic alliance intended to create a vertically-integrated cannabis operation with a global footprint spanning cultivation, IP generation, […]

5

LGC Capital signs letter of intent for proposed acquisition of 20% of Etea Sicurezza Group Ltd

MONTREAL, Nov. 1, 2017  – LGC Capital Ltd. (TSXV: LG) (“LGC“) is pleased to announce that it has entered into a letter of intent with Etea Sicurezza Group Ltd (“Etea Sicurezza”) for a potential acquisition of approximately 20% of Etea Sicurezza by LGC. The letter of intent will form the basis for the negotiation of a mutually-satisfactory definitive agreement to be […]

6

LGC Capital Signs First Canadian Cannabis Deal In Quebec

MONTREAL, Oct. 31, 2017 – LGC Capital Ltd. (TSXV: LG) (“LGC”) is pleased to announce that it has signed an option with Quebecbased Tricho-Med Corporation, doing business as AAA Trichomes (AAA Trichomes) to acquire a 49% interest (plus a 5% royalty) in a new cannabis processing facility to be built in the Province of Quebec. Subject to permitting, the AAA Trichomes […]

7

LGC Capital Completes Acquisition of Initial Strategic Interest in Licenced Australian Medical Cannabis Company – Little Green Pharma

MONTREAL, Oct. 12, 2017 – LGC Capital Ltd. (TSXV: LG) (“LGC”) is pleased to announce that it has today completed the acquisition of stage one of its strategic interest in licenced Australian Medical Cannabis company Habi Pharma Pty Ltd of Perth, Australia, doing business as “Little Green Pharma”, as announced on September 26, 2017 and October 5, 2017. On October 5, 2017, the Company announced that […]

8

LGC Capital Announces Merchant Banking Division And New Opportunity

Montreal, Québec – October 10, 2017 – LGC Capital Ltd. (TSXV: LG) (“LGC”) is pleased to announce that it has formally established a merchant banking division within its business, which will pursue global high-yield investment opportunities. This new division will run parallel with and will not deter efforts from LGC’s cannabis investments and the pursuit of additional […]

9

LGC Capital Signs Definitive Agreement to Acquire Strategic Interest in Licenced Australian Medical Cannabis Company – Little Green Pharma

TSX Venture Exchange authorizes LGC to proceed to closing of the transaction, scheduled for Tuesday, October 10, 2017 MONTREAL, Oct. 5, 2017 – LGC Capital Ltd. (TSXV: LG) (“LGC”) is pleased to announce that it has entered into a definitive Subscription Agreement with licenced Australian Medical Cannabis company Habi Pharma Pty Ltd of Perth, Australia, doing business as “Little Green Pharma”, for […]

10

LGC Capital Signs Binding Term Sheet to Acquire Strategic Interest in Licenced Australian Medical Cannabis Company – Little Green Pharma

MONTREAL, Sept. 26, 2017 – LGC Capital Ltd. (TSXV: LG) (“LGC”) announces that it has entered into a binding term sheet with Habi Pharma Pty Ltd of Perth, Australia, doing business as “Little Green Pharma“, which provides that LGC will acquire an initial strategic 4.99% interest in Little Green Pharma, one of the few licenced companies authorized to […]

11

LGC Capital Ltd. Exits All Investment Activity Associated With Cuba To Focus On Its Global Medical Cannabis Initiatives And Other Investment Opportunities

Montreal, Québec – September 26, 2017 – LGC Capital Ltd. (TSXV: LG) (“LGC”) announces that its Board of Directors has resolved to immediately exit all current investments, partnerships and joint venture arrangements with companies or entities that have any business activities relating to Cuba. While LGC continues to be positive towards the investment opportunities in Cuba, regrettably […]

12

LGC Capital Ltd. Updates Corporate Presentation

MONTREAL, Sept. 19, 2017  – LGC Capital Ltd. (TSXV: LG)(“LGC“) announces that it has updated its Corporate Presentation, which is available on LGC’s web site (www.lgc-capital.com), as well as certain information on the web site to reflect the changing nature of its businesses and investments. The Corporate Presentation and web site, as updated, specify that LGC’s joint […]

13

LGC Capital Ltd. announces Director resignation

MONTREAL, Sept. 18, 2017  – LGC Capital Ltd. (TSXV: QBA) (“LGC“) announces the resignation of Mr. Sébastien Bellefleur as a Director of the Corporation effective September 13, 2017. The Board of Directors wishes to thank Mr. Bellefleur for his contribution to LGC Capital and wishes him every success in his future endeavours.  The Corporation will initiate a search for a new director […]

14

LGC Capital Ltd. to change stock symbol to “LG”

MONTREAL, Sept. 14, 2017 – LGC Capital Ltd. (TSXV: QBA) (“LGC“) announces that its stock symbol will change to “LG” effective at the opening of the markets on Monday, September 18, 2017.  Until that time, LGC’s shares will continue to trade under the current stock symbol “QBA”.  LGC’s shares are listed on the TSX Venture Exchange. About LGC (http://www.lgc-capital.com) LGC Capital Ltd. is […]

15

LGC Capital Ltd. Raises $2,630,616 at First Closing of Private Placement

MONTREAL, Sept.11, 2017 – LGC Capital Ltd. (TSXV: QBA) (“LGC”) is pleased to announce that it has raised gross proceeds of $2,630,616 at a first closing of its previously-announced private placement by issuing 26,306,160 units at a price of $0.10 per unit. LGC expects to hold a final closing for the balance of 3,693,840 units ($369,384) by Wednesday, September 13, […]